30 July 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is pleased to announce that it has successfully achieved institutional accreditation from the Royal College of Physicians and Surgeons of
A French Family's Journey of Trust and Recovery at Sidra Medicine 23 July 2024, Doha, Qatar – A six-year old boy, born with a rare condition called a nasal meningoencephalocele, underwent
Partnership to enable Nursing Best Practices and Excellence Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with Children’s National Hospital from Washington D.C., to establish a
Life-saving drug from Roche Pharmaceuticals now available in Qatar for children with Duchenne Muscular Dystrophy Chris El Kik becomes first patient to receive treatment for DMD Doha, Qatar, 1 July
Hope for Patients with Complex Medical Conditions and Rare Diseases 30 June 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is pleased to announce that it has successfully implemented
QF Entity recognizes 2023-2024 academic batch of residents, fellows and sponsored students. 09 June 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, celebrated its second Medical Education Day on
15 May 2024, Doha, Qatar – Sidra Medicine, in collaboration with the MENAT-NIAID initiative, proudly hosted the Recent Advances in Primary Immunodysregulation Disorders (RAPID) conference on the 9th and 10th of
QF Entity Partners with Children’s Hospital of Philadelphia 14 May 2024, Doha, Qatar – Sidra Medicine, a QF entity, is proud to announce the upcoming establishment of the first-ever pediatric hematopoietic stem
A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the prestigious Genome Medicine journal1.
